JHEP Reports Internal Medicine

Biomarkers associated with efficacy of first-line nivolumab vs. sorafenib in advanced hepatocellular carcinoma: Results from the CheckMate 459 phase III trial

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →